Forbion Leads €17m Series C Financing of OMEICOS Therapeutics
Forbion invests €12.5m from its recently launched Forbion IV fund
OMEICOS is pioneering the development of stable analogs of omega-3 fatty acid metabolites for Cardiovascular Disease and Ophthalmology
Forbion, a leading European life science…